LEO Pharma Appoints Marika Murto as SVP of Global Product Strategy Effective February 1, 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 16 2025
0mins
Source: Businesswire
- Leadership Change: LEO Pharma announces the appointment of Dr. Marika Murto as Senior Vice President of Global Product Strategy effective February 1, 2026, leveraging her extensive experience at Amgen to drive the strategic direction of the company's product portfolio and enhance market competitiveness.
- Industry Background: During her tenure at Amgen as U.S. Commercial Lead for Bone Health, Marika successfully drove strategic brand positioning, showcasing her ability to manage complex portfolios in diverse markets, which will provide valuable market insights for LEO Pharma.
- Strategic Vision: Marika emphasizes that effective product strategy requires uniting science, market insight, and organizational excellence, and she is expected to enhance patient outcomes and sustainable growth at LEO Pharma by empowering diverse teams and fostering innovation.
- Transition Management: Prior to Marika's arrival, Lisa Elliot will continue to serve as interim head of Global Product Strategy, ensuring strategic continuity and the retention of expertise during the transition period.
Analyst Views on LEO
About LEO
BNY Mellon Strategic Municipals, Inc. (the Fund) is a diversified closed-end management investment company. The Fund’s investment objective is to maximize income exempt from federal income tax to the extent consistent with the preservation of capital. BNY Mellon Investment Adviser, Inc. (the Adviser) serves as the fund’s investment adviser. Under normal market conditions, the fund invests at least 80% of its net assets in municipal obligations. Generally, the fund invests at least 50% of its net assets in municipal bonds considered investment grade or the unrated equivalent as determined by BNY Mellon Investment Adviser, Inc. in the case of bonds, and in the two categories or the unrated equivalent as determined by the Adviser in the case of short-term obligations having or deemed to have maturities of less than one year. BNY Mellon Investment Adviser, Inc. serves as investment adviser of the Fund.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





